BTAI BioXcel Therapeutics, Inc. - Common Stock
$0,84
Preço · Ago 18, 2026
Fundamentais a partir de Ago 13, 2026
Intervalo 52 Semanas
$1–$6
2% of range
Classificação do Analista
BUY
11 analysts
Preço-Alvo
$14
+1574% upside
P/E (TTM)
-0.2
ROE
68.8%
Margem de Lucro Líquido
-10887.4%
BTAI Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$0.84
Capitalização de Mercado
$23M
P/E (TTM)
-0.2
EPS (TTM)
$-5.73
Receita (TTM)
$642.0K
Rendimento div.
—
ROE
68.8%
Dívida/Capital
-1.1
Intervalo 52 Semanas
$1 – $6
BTAI Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$642.0K
2022-12-31
→
2025-12-31
EPS
$-5.73
2020-12-31
→
2025-12-31
Fluxo de caixa livre
$-58M
2018-12-31
→
2025-12-31
Margens
-10887.4%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
BTAI
Mediana de Pares
P/E (TTM)
-0.2
0.8
P/S (TTM)
35.3
6.2
P/B
-0.2
3.0
EV / EBITDA
-2.1
—
Price / FCF (Preço / FCF)
-0.4
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
BTAI
Mediana de Pares
Operating Margin (Margem Operacional)
-7860.0%
—
Net Profit Margin (Margem de Lucro Líquido)
-10887.4%
-1056.6%
ROA
-167.9%
-118.6%
ROE
68.8%
-139.5%
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
BTAI
Mediana de Pares
Debt / Equity (Dívida / Patrimônio Líquido)
-1.1
—
Current Ratio (Índice de liquidez corrente)
0.8
2.1
Quick Ratio (Índice de Liquidez Seca)
0.5
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
BTAI
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-71.7%
—
Revenue CAGR 3Y (CAGR Receita 3A)
19.6%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
BTAI
Mediana de Pares
BTAI Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
11 analistas
- Compra forte 2 18,2%
- Compra 7 63,6%
- Manter 1 9,1%
- Venda 1 9,1%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
4 analistas · 2026-08-14
Mediana
$8.50
Média
$14.00
← Abaixo de todos os alvos
$0.84
Mín
$1.00
Máx
$38.00
Alvo mediano
$8.50
+916,6%
Alvo médio
$14.00
+1574,4%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
1.2%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-0.54 | $-0.84 | 0.30% |
| 31 de Dezembro de 2025 | $-0.58 | $-0.77 | 0.18% |
| 30 de Setembro de 2025 | $-2.18 | $-1.20 | -0.98% |
| 30 de Junho de 2025 | $-2.45 | $-1.89 | -0.56% |
| 31 de Março de 2025 | $-1.50 | $-6.79 | 5.3% |
| 31 de Dezembro de 2024 | $-3.57 | $-6.55 | 3.0% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| BTAI | $36M | -0.3 | -71.7% | -10887.4% | 68.8% | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| NXTC | $50M | -0.7 | — | — | -172.9% | — |
| QNCX | $187M | -2.0 | — | — | 700.5% | — |
| BYSI | — | — | — | — | 3.1% | — |
| LTRN | — | -1.9 | — | — | — | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $642.0K | $2M | $1M | $375.0K | |
| Cost of Revenue | $164.0K | $2M | $1M | $20.0K | |
| R&D Expense | $30M | $30M | $84M | $91M | |
| SG&A Expense | $20M | $34M | $83M | $69M | |
| Operating Expenses | $51M | $70M | $173M | $160M | |
| Operating Income | $-50M | $-67M | $-172M | $-160M | |
| Interest Expense | · | · | $13M | $8M | |
| Interest Income | $1M | $3M | $6M | $3M | |
| Other Non-op | $-4M | $20M | $394.0K | $-427.0K | |
| Income Tax | $0 | $0 | $0 | · | |
| Net Income | $-70M | $-60M | $-179M | $-166M | |
| EPS (Basic) | $-5.73 | $-23.51 | $-98.33 | $-5.92 | |
| EPS (Diluted) | $-5.73 | $-23.51 | $-98.33 | $-5.92 | |
| Shares (Basic) | 12,208,000 | 2,535,000 | 1,821,000 | 28,015,000 | |
| Shares (Diluted) | 12,208,000 | 2,535,000 | 1,821,000 | 28,015,000 | |
| EBITDA | $-50M | $-67M | $-172M | · |
Balanço Patrimonial 24
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $30M | $65M | $194M | |
| Receivables | $233.0K | $131.0K | $71.0K | $248.0K | |
| Inventory | $722.0K | $679.0K | $2M | $2M | |
| Prepaid Expense | $4M | $5M | $3M | $3M | |
| Other Current Assets | $11M | $1M | $2M | $4M | |
| Current Assets | $45M | $37M | $72M | $203M | |
| PP&E (Net) | $175.0K | $475.0K | $784.0K | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $885.0K | |
| Other Non-current Assets | $0 | $87.0K | $87.0K | $925.0K | |
| Total Assets | $45M | $38M | $74M | $206M | |
| Accounts Payable | $15M | $16M | $14M | $10M | |
| Accrued Liabilities | $4M | $6M | $12M | $19M | |
| Current Liabilities | $54M | $22M | $27M | $33M | |
| Capital Leases | $0 | $65.0K | $440.0K | $786.0K | |
| Total Liabilities | $140M | $131M | $130M | $129M | |
| Long-term Debt | $110M | $103M | · | · | |
| Total Debt | $110M | $103M | $101M | · | |
| Common Stock | $76.0K | $49.0K | $30.0K | $28.0K | |
| Paid-in Capital | $625M | $557M | $534M | $488M | |
| Retained Earnings | $-720M | $-650M | $-591M | $-412M | |
| Stockholders' Equity | $-95M | $-93M | $-57M | $77M | |
| Liabilities + Equity | $45M | $38M | $74M | $206M | |
| Shares Outstanding | 22,328,000 | 3,102,000 | 1,871,000 | 1,759,000 |
Fluxo de Caixa 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $3M | $6M | $19M | $17M | |
| Restructuring | $194.0K | $2M | $4M | · | |
| Operating Cash Flow | $-58M | $-72M | $-155M | $-135M | |
| CapEx | $0 | $0 | $20.0K | $139.0K | |
| Investing Cash Flow | $0 | $0 | $-20.0K | $-139.0K | |
| Debt Issued | · | · | · | $99M | |
| Net Debt Issued | $0 | $-2M | · | · | |
| Stock Issued | · | · | $27M | · | |
| Net Stock Activity | · | · | $27M | · | |
| Financing Cash Flow | $57M | $37M | $27M | $96M | |
| Net Change in Cash | $-1M | $-35M | $-129M | $-39M | |
| Free Cash Flow | $-58M | · | $-155M | · |
Lucratividade 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -7860.0% | -2967.6% | -12448.0% | · | |
| Net Margin | -10887.4% | -2630.1% | -12974.9% | · | |
| EBITDA Margin | -7860.0% | -2967.6% | -12448.0% | · | |
| ROA | -167.9% | -106.4% | -128.1% | · | |
| ROE | 68.8% | 66.7% | 368.7% | · |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.7 | 2.6 | · | |
| Quick Ratio | 0.5 | 1.3 | 2.4 | · | |
| Debt / Equity | -1.1 | -1.1 | -1.8 | · | |
| LT Debt / Equity | -0.9 | -1.1 | -1.8 | · | |
| Interest Coverage | · | · | -12.9 | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 0.2 | 1.6 | 0.6 | · | |
| Receivables Turnover | 3.5 | 22.4 | 8.7 | · |
Taxas de Crescimento 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | -71.7% | 64.2% | 268.0% | · | |
| Revenue CAGR 3Y | 19.6% | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $642.0K | $2M | $1M | $375.0K | |
| Net Income TTM | $-70M | $-60M | $-179M | $-166M | |
| Market Cap | $36M | $19M | $1.41B | · | |
| Enterprise Value | $117M | $91M | $1.45B | · | |
| P/E | -0.3 | -0.3 | -0.5 | -58.1 | |
| P/S | 55.6 | 8.2 | 1023.7 | · | |
| P/B | -0.4 | -0.2 | -25.0 | · | |
| P / Tangible Book | · | · | · | 126.0 | |
| P / Cash Flow | -0.6 | -0.3 | -9.1 | · | |
| P / FCF | -0.6 | · | -9.1 | · | |
| EV / EBITDA | -2.3 | -1.4 | -8.4 | · | |
| EV / FCF | -2.0 | · | -9.3 | · | |
| EV / Revenue | 182.1 | 40.3 | 1049.3 | · | |
| Earnings Yield | -358.1% | -392.9% | -208.3% | -1.7% |
Demonstração de Resultados 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $182.0K | $206.0K | $256.0K | $98.0K | $120.0K | $168.0K | $366.0K | $214.0K | $1M | $582.0K | $376.0K | $341.0K | $457.0K | $206.0K | $238.0K | $137.0K | |
| Cost of Revenue | $22.0K | $283.0K | $32.0K | $11.0K | $107.0K | $14.0K | $831.0K | $1M | $62.0K | $80.0K | $713.0K | $512.0K | $26.0K | $9.0K | $9.0K | $11.0K | |
| R&D Expense | $3M | $3M | $7M | $9M | $10M | $5M | $6M | $5M | $8M | $11M | $10M | $20M | $27M | $28M | $33M | $22M | |
| SG&A Expense | $7M | $7M | $4M | $5M | $6M | $6M | $4M | $8M | $9M | $13M | $10M | $24M | $26M | $24M | $20M | $17M | |
| Operating Expenses | $10M | $10M | $11M | $14M | $16M | $10M | $11M | $16M | $18M | $25M | $20M | $49M | $53M | $51M | $53M | $39M | |
| Operating Income | $-10M | $-10M | $-10M | $-14M | $-16M | $-10M | $-10M | $-15M | $-17M | $-24M | $-20M | $-48M | $-52M | $-51M | $-53M | $-39M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $3M | $3M | $3M | $3M | $4M | |
| Interest Income | $131.0K | $211.0K | $321.0K | $236.0K | $230.0K | $279.0K | $368.0K | $616.0K | $671.0K | $947.0K | $945.0K | $1M | $2M | $2M | $1M | $823.0K | |
| Other Non-op | $-394.0K | $2M | $2M | $-13M | $657.0K | $7M | $3M | $5M | $12M | $32.0K | $108.0K | $-5.0K | $537.0K | $-246.0K | $-480.0K | $62.0K | |
| Net Income | $-15M | $-13M | $-13M | $-31M | $-19M | $-7M | $-11M | $-14M | $-8M | $-27M | $-22M | $-50M | $-54M | $-53M | $-55M | $-42M | |
| EPS (Basic) | $-0.49 | $-0.54 | $0.40 | $-2.18 | $-2.45 | $-1.50 | $-1.17 | $-5.15 | $-3.30 | $-13.89 | $-92.94 | $-1.72 | $-1.83 | $-1.84 | $-1.96 | $-1.49 | |
| EPS (Diluted) | $-0.49 | $-0.54 | $0.40 | $-2.18 | $-2.45 | $-1.50 | $-1.17 | $-5.15 | $-3.30 | $-13.89 | $-92.94 | $-1.72 | $-1.83 | $-1.84 | $-1.96 | $-1.49 | |
| Shares (Basic) | 30,300,000 | 23,571,000 | -14,665,000 | 14,196,000 | 7,843,000 | 4,834,000 | -4,559,000 | 2,649,000 | 2,516,000 | 1,929,000 | -85,250,000 | 29,268,000 | 29,187,000 | 28,616,000 | -55,976,000 | 28,022,000 | |
| Shares (Diluted) | 30,300,000 | 23,571,000 | -14,665,000 | 14,196,000 | 7,843,000 | 4,834,000 | -4,559,000 | 2,649,000 | 2,516,000 | 1,929,000 | -85,250,000 | 29,268,000 | 29,187,000 | 28,616,000 | -28,023,980 | 28,022,000 | |
| EBITDA | $-10M | · | · | $-14M | $-16M | $-10M | · | $-15M | $-17M | $-24M | · | $-48M | $-52M | $-51M | · | $-39M |
Balanço Patrimonial 24
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $17M | $28M | $36M | $17M | $31M | $30M | $40M | $56M | $74M | $65M | $90M | $128M | $166M | $194M | $232M | |
| Receivables | $82.0K | $216.0K | $233.0K | $0 | $17.0K | · | $131.0K | $3.0K | $812.0K | $378.0K | $71.0K | $735.0K | $431.0K | $283.0K | $248.0K | · | |
| Inventory | $483.0K | $500.0K | $722.0K | $459.0K | $506.0K | $642.0K | $679.0K | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Prepaid Expense | $3M | $4M | $4M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $3M | $4M | $4M | $5M | $3M | $6M | |
| Other Current Assets | $11M | $12M | $11M | $934.0K | $995.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $5M | $5M | $4M | $2M | |
| Current Assets | $29M | $34M | $45M | $44M | $25M | $38M | $37M | $48M | $64M | $81M | $72M | $99M | $138M | $177M | $203M | $242M | |
| PP&E (Net) | $99.0K | $117.0K | $175.0K | $249.0K | $324.0K | $399.0K | $475.0K | $552.0K | $629.0K | $706.0K | $784.0K | $862.0K | $941.0K | $1M | $1M | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $965.0K | $885.0K | $848.0K | |
| Other Non-current Assets | · | · | $0 | $0 | · | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $925.0K | $925.0K | $925.0K | |
| Total Assets | $29M | $34M | $45M | $45M | $26M | $39M | $38M | $49M | $65M | $82M | $74M | $100M | $140M | $180M | $206M | $245M | |
| Accounts Payable | $19M | $16M | $15M | $16M | $17M | $15M | $16M | $15M | $13M | $17M | $14M | $11M | $11M | $8M | $10M | $6M | |
| Accrued Liabilities | $4M | $6M | $4M | $4M | $5M | $4M | $6M | $10M | $13M | $14M | $12M | $27M | $19M | $17M | $19M | $14M | |
| Current Liabilities | $137M | $55M | $54M | $38M | $33M | $26M | $22M | $26M | $27M | $31M | $27M | $39M | $35M | $29M | $33M | $23M | |
| Capital Leases | · | · | $0 | $0 | · | · | $65.0K | $161.0K | $256.0K | $350.0K | $440.0K | $529.0K | $617.0K | $703.0K | $786.0K | $868.0K | |
| Total Liabilities | $144M | $140M | $140M | $134M | $133M | $129M | $131M | $135M | $140M | $155M | $130M | $141M | $134M | $127M | $129M | $118M | |
| Long-term Debt | $104M | $100M | $110M | $109M | $109M | $106M | $103M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $104M | · | · | $109M | $109M | $106M | · | $104M | $103M | $102M | · | $99M | $97M | $95M | · | $92M | |
| Common Stock | $31.0K | $27.0K | $76.0K | $73.0K | $60.0K | $59.0K | $49.0K | $42.0K | $40.0K | $34.0K | $30.0K | $29.0K | $29.0K | $29.0K | $28.0K | $28.0K | |
| Paid-in Capital | $632M | $627M | $625M | $619M | $569M | $567M | $557M | $554M | $551M | $545M | $534M | $528M | $524M | $517M | $488M | $484M | |
| Retained Earnings | $-747M | $-733M | $-720M | $-708M | $-677M | $-657M | $-650M | $-639M | $-626M | $-617M | $-591M | $-568M | $-518M | $-464M | $-412M | $-357M | |
| Stockholders' Equity | $-115M | $-106M | $-95M | $-89M | $-108M | $-90M | $-93M | $-86M | $-74M | $-72M | $-57M | $-41M | $6M | $53M | $77M | $127M | |
| Liabilities + Equity | $29M | $34M | $45M | $45M | $26M | $39M | $38M | $49M | $65M | $82M | $74M | $100M | $140M | $180M | $206M | $245M | |
| Shares Outstanding | 31,305,000 | 27,075,000 | 22,328,000 | 19,996,000 | 6,620,000 | 5,468,000 | 3,102,000 | 42,462,000 | 40,383,000 | 33,632,000 | 1,871,000 | 29,273,000 | 29,267,000 | 29,100,000 | 28,147,000 | 28,023,000 |
Fluxo de Caixa 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $358.0K | $435.0K | $450.0K | $581.0K | $2M | $180.0K | $-199.0K | $2M | $1M | $3M | $4M | $4M | $6M | $5M | $5M | $4M | |
| Restructuring | · | $0 | $0 | $194.0K | $0 | $0 | $32.0K | $2M | $856.0K | · | $0 | $4M | · | · | · | · | |
| Operating Cash Flow | $-6M | $-12M | $-14M | $-19M | $-13M | $-12M | $-15M | $-16M | $-23M | $-18M | $-27M | $-38M | $-38M | $-52M | $-39M | $-31M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $30M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $25M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | · | · | |
| Financing Cash Flow | $3M | $232.0K | $6M | $38M | $137.0K | $13M | $4M | $454.0K | $5M | $27M | $2M | $0 | $250.0K | $24M | $50.0K | $30M | |
| Net Change in Cash | $-3M | $-12M | $-9M | $19M | $-12M | $1M | $-11M | $-16M | $-18M | $9M | $-25M | $-38M | $-38M | $-28M | $-39M | $-1M |
Lucratividade 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5600.6% | · | · | -14518.4% | -13210.0% | -6011.3% | · | -7146.3% | -1566.7% | -4151.7% | · | -14163.3% | -11469.1% | -24853.4% | · | -28459.8% | |
| Net Margin | -8084.1% | · | · | -31541.8% | -15989.2% | -4317.9% | · | -6378.5% | -751.7% | -4603.3% | · | -14805.3% | -11710.1% | -25629.1% | · | -30514.6% | |
| EBITDA Margin | -5600.6% | · | · | -14518.4% | -13210.0% | -6011.3% | · | -7146.3% | -1566.7% | -4151.7% | · | -14163.3% | -11469.1% | -24853.4% | · | -28459.8% | |
| ROA | -53.9% | · | · | -66.0% | -42.1% | -12.0% | · | -18.3% | -8.1% | -20.4% | · | -29.2% | -27.6% | -27.0% | · | -16.5% | |
| ROE | 13.2% | · | · | 35.4% | 21.1% | 8.9% | · | 21.6% | 24.2% | 276.8% | · | -116.9% | -62.9% | -42.8% | · | -22.4% |
Liquidez e Solvência 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | · | · | 1.2 | 0.8 | 1.5 | · | 1.9 | 2.4 | 2.6 | · | 2.5 | 4.0 | 6.2 | · | 10.3 | |
| Quick Ratio | 0.1 | · | · | 1.0 | 0.5 | 1.2 | · | 1.6 | 2.1 | 2.4 | · | 2.3 | 3.7 | 5.8 | · | 9.9 | |
| Debt / Equity | -0.9 | · | · | -1.2 | -1.0 | -1.2 | · | -1.2 | -1.4 | -1.4 | · | -2.4 | 16.5 | 1.8 | · | 0.7 | |
| LT Debt / Equity | 0.0 | · | · | -1.0 | -0.9 | -1.1 | · | -1.2 | -1.4 | -1.4 | · | -2.4 | 16.5 | 1.8 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6.7 | · | -14.9 | -16.1 | -15.2 | · | -10.5 |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | · | · | 0.0 | 0.1 | 0.0 | · | 0.7 | 0.0 | 0.0 | · | 0.3 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 3.7 | · | · | 65.3 | 0.3 | · | · | 0.6 | 1.8 | 1.8 | · | 0.9 | 2.1 | 1.5 | · | · |
Avaliação (TTM) 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606.0K | $592.0K | · | $600.0K | $2M | $2M | · | $2M | $2M | $2M | · | $1M | · | · | · | · | |
| Net Income TTM | $-78M | $-70M | · | $-71M | $-48M | $-56M | · | $-99M | $-139M | $-184M | · | $-199M | $-186M | $-164M | · | $-138M | |
| Market Cap | $44M | · | · | $51M | $12M | $11M | · | $414M | $827M | $1.52B | · | $1.18B | $3.12B | $8.69B | · | $5.30B | |
| Enterprise Value | $136M | · | · | $124M | $103M | $86M | · | $478M | $874M | $1.54B | · | $1.19B | $3.09B | $8.62B | · | $5.16B | |
| P/E | -0.2 | -0.2 | · | -0.2 | -0.1 | -0.1 | · | -0.4 | -1.0 | -2.3 | · | -5.9 | -16.4 | -51.5 | · | -38.4 | |
| P/S | 72.8 | · | · | 85.3 | 7.5 | 5.4 | · | 184.9 | 332.9 | 956.8 | · | 1038.5 | · | · | · | · | |
| P/B | -0.4 | · | · | -0.6 | -0.1 | -0.1 | · | -4.8 | -11.1 | -21.0 | · | -29.2 | 531.8 | 163.9 | · | 41.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 531.8 | 163.9 | · | 41.7 | |
| P / Cash Flow | · | · | · | · | · | -0.9 | · | · | · | -85.7 | · | · | · | -166.0 | · | · | |
| EV / EBITDA | -13.3 | · | · | -8.7 | -6.5 | -8.5 | · | -31.3 | -50.5 | -63.9 | · | -24.7 | -58.9 | -168.3 | · | -132.3 | |
| EV / Revenue | 224.0 | · | · | 206.9 | 64.3 | 41.4 | · | 213.5 | 351.8 | 974.1 | · | 1046.5 | · | · | · | · | |
| Earnings Yield | -401.4% | -497.8% | · | -440.6% | -685.1% | -1174.4% | · | -246.5% | -101.3% | -42.7% | · | -17.0% | -6.1% | -1.9% | · | -2.6% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $642.0K | $2M | $1M | $375.0K | — |
| Margem Operacional % | -7860.0% | -2967.6% | -12448.0% | — | — |
| Lucro líquido | $-70M | $-60M | $-179M | $-166M | $-107M |
| EPS Diluído | $-5.73 | $-23.51 | $-98.33 | $-5.92 | $-4.05 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | -1.1 | -1.1 | -1.8 | — | — |
| Índice de liquidez corrente | 0.8 | 1.7 | 2.6 | — | 14.2 |
| Índice de Liquidez Seca | 0.5 | 1.3 | 2.4 | — | 14.0 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-58M | — | $-155M | — | $-83M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 50 declarantes · $8.5M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 14 (+9 vs trimestre anterior) | 3 (-5 vs trimestre anterior) | 7 (-2 vs trimestre anterior) | 9 (+3 vs trimestre anterior) | +725K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $2.981.741 | 2.114.710 | 35,24% | Ações |
| OAKTREE CAPITAL MANAGEMENT LP | $1.946.150 | 1.380.248 | 23,00% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.296.558 | 919.545 | 15,32% | Ações |
| Oaktree Fund Advisors, LLC | $346.274 | 245.585 | 4,09% | Ações |
| VANGUARD GROUP INC | $331.742 | 207.339 | 3,92% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $284.141 | 201.279 | 3,36% | Ações |
| CITADEL ADVISORS LLC | $210.400 | 149.220 | 2,49% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $193.081 | 136.937 | 2,28% | Ações |
| STATE STREET CORP | $129.886 | 92.118 | 1,54% | Ações |
| FMR LLC | $127.323 | 90.300 | 1,50% | Ações |
| &PARTNERS | $117.859 | 83.588 | 1,39% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $82.712 | 63.139 | 0,98% | Ações |
| NORTHERN TRUST CORP | $79.407 | 56.317 | 0,94% | Ações |
| HighTower Advisors, LLC | $57.810 | 41.000 | 0,68% | Ações |
| Quadrature Capital Ltd | $53.634 | 38.038 | 0,63% | Ações |
| Headlands Technologies LLC | $36.034 | 25.556 | 0,43% | Ações |
| StoneX Group Inc. | $29.164 | 20.684 | 0,34% | Ações |
| Beacon Pointe Advisors, LLC | $25.296 | 18.877 | 0,30% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24.252 | 17.200 | 0,29% | Ações |
| Portfolio Strategies, Inc. | $23.732 | 16.831 | 0,28% | Ações |
| OSAIC HOLDINGS, INC. | $22.860 | 16.214 | 0,27% | Ações |
| TWO SIGMA SECURITIES, LLC | $15.222 | 10.796 | 0,18% | Ações |
| DIVERSIFY WEALTH MANAGEMENT, LLC | $13.005 | 15.000 | 0,15% | Ações |
| Diversify Advisory Services, LLC | $13.005 | 15.000 | 0,15% | Ações |
| BlackRock, Inc. | $8.384 | 5.946 | 0,10% | Ações |
| CITIGROUP INC | $4.227 | 2.998 | 0,05% | Ações |
| BARCLAYS PLC | $2.013 | 1.428 | 0,02% | Ações |
| NewEdge Advisors, LLC | $1.877 | 1.331 | 0,02% | Ações |
| Vanguard Global Advisers, LLC | $695 | 493 | 0,01% | Ações |
| Silver Grove Financial Group, Inc. | $468 | 331 | 0,01% | Ações |
| AllSquare Wealth Management LLC | $448 | 175 | 0,01% | Ações |
| Tower Research Capital LLC (TRC) | $320 | 227 | 0,00% | Ações |
| MORGAN STANLEY | $313 | 222 | 0,00% | Ações |
| UBS Group AG | $214 | 152 | 0,00% | Ações |
| Parkside Financial Bank & Trust | $151 | 112 | 0,00% | Ações |
| Washington Trust Advisors, Inc. | $116 | 82 | 0,00% | Ações |
| EverSource Wealth Advisors, LLC | $85 | 60 | 0,00% | Ações |
| JPMORGAN CHASE & CO | $63 | 45 | 0,00% | Ações |
| MERCER GLOBAL ADVISORS INC /ADV | $45 | 32 | 0,00% | Ações |
| Farther Finance Advisors, LLC | $35 | 25 | 0,00% | Ações |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $30 | 21 | 0,00% | Ações |
| WELLS FARGO & COMPANY/MN | $25 | 18 | 0,00% | Ações |
| Virtu Financial LLC | $23 | 15.967 | 0,00% | Ações |
| SBI Securities Co., Ltd. | $18 | 13 | 0,00% | Ações |
| IFP Advisors, Inc | $18 | 13 | 0,00% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $17 | 12 | 0,00% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $3 | 2 | 0,00% | Ações |
| US BANCORP \DE\ | $1 | 1 | 0,00% | Ações |
| Triumph Capital Management | $1 | 1 | 0,00% | Ações |
| GROUP ONE TRADING LLC | $1 | 1 | 0,00% | Ações |
Executivos da empresa 19 insiders · 6 diretores · 9 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Vimal Mehta | CEO and President | 15 de Junho de 2026 M | 69.817 | 0 | 1 | $-21.167 |
| Richard I Steinhart | Chief Financial Officer | 15 de Junho de 2026 M | 26.335 | 0 | 1 | $-7.393 |
| Javier Rodriguez | Chief Legal Officer, Senior Vice President and Corporate Secretary | 15 de Junho de 2026 M | 26.838 | 0 | 1 | $-7.085 |
| Frank Yocca | Chief Scientific Officer | 15 de Junho de 2026 M | 26.210 | 0 | 1 | $-7.393 |
| William P Kane Jr | Chief Commercial Officer | 16 de Agosto de 2021 A | — | 0 | 0 | $0 |
| Reina Benabou | Senior Vice President Clinical Research Neuroscience and Chief Development Officer | 22 de Junho de 2020 A | — | 0 | 0 | $0 |
| June Bray | Conselheiro | 9 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Sandeep Laumas | Conselheiro | 9 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| David J. Mack | Conselheiro | 9 de Janeiro de 2026 A | 20.317 | 0 | 0 | $0 |
| Michal Votruba | Conselheiro | 9 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Rajiv Patni | Conselheiro | 9 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Peter Mueller | Conselheiro | 9 de Janeiro de 2026 A | 90.000 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | Conselheiro | 9 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Krishnan Nandabalan | Conselheiro | 6 de Abril de 2023 M | 0 | 0 | 0 | $0 |
| Susan E. Atkins | — | 12 de Agosto de 2026 A | — | 0 | 0 | $0 |
| Matthew T. Wiley | — | 22 de Julho de 2024 A | 19.011 | 0 | 0 | $0 |
| Vincent O'Neill | — | 22 de Julho de 2024 A | 19.957 | 0 | 0 | $0 |
| BioXcel Holdings, Inc. | — | 25 de Junho de 2021 S | 8.546.750 | 0 | 0 | $0 |
| BioXcel Corp | — | 25 de Junho de 2021 S | 8.546.750 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| BioXcel LLC, BioXcel Holdings, Inc., Vimal Mehta ×2 declarações | 6 de Junho de 2024 | — | Declaração inicial | — | SEC |
| DNCA FINANCE S.C.S ×4 declarações | 6 de Março de 2020 | — | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 3 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.